Loading organizations...
§ Private Profile · Amsterdam, Noord-Holland, The Netherlands
Genomics and immunotherapy developer targeting genetic suppressors.
Scenic Biotech has raised $38.4M across 2 funding rounds.
Scenic Biotech has raised $38.4M in total across 2 funding rounds.
Scenic Biotech has raised $38.4M across 2 funding rounds. Most recently, it raised $31.0M Series A in March 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 11, 2022 | $31M Series A | Michael Wacker, Stephan Christgau, Stephane Verdood | BioGeneration Ventures, INKEF Capital, Oxford Science Enterprises | Announced |
| Jul 3, 2017 | $7.4M Series A | BioGeneration Ventures, INKEF Capital | Oxford Science Enterprises | Announced |
Scenic Biotech has raised $38.4M in total across 2 funding rounds.
Scenic Biotech's investors include Michael Wacker, Stephan Christgau, Stephane Verdood, BioGeneration Ventures, INKEF Capital, Oxford Science Enterprises.